SEARCH

SEARCH BY CITATION

References

  • 1
    Vieth, R. (2004) Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. Journal of Steroid Biochemistry and Molecular Biology, 89–90, 575579.
  • 2
    Holick, M.F. (1999) Vitamin D: photobiology, metabolism, mechanism of action and clinical application. In: M.J.Favus ed. Primer on the Metabolic Bone Diseases and Mineral Metabolism, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, 9298.
  • 3
    Holick, M.F. (2003) Evolution and function of vitamin D. Recent Results in Cancer Research, 164, 328.
  • 4
    Blunt, J.W., DeLuca, H.F. & Schnoes, H.K. (1968) 25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry, 7, 33173322.
  • 5
    Fraser, D.R. & Kodicek, E. (1970) Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature, 228, 764766.
  • 6
    Leheste, J.R., Melsen, F., Wellner, M., Jansen, P., Schlichting, U., Renner-Müller, I., Andreassen, T., Wolf, E., Bachmann, S., Nykjaer, A. & Wilnow, T. (2003) Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. The FASEB Journal, 17, 247249.
  • 7
    Brown, A.J., Dusso, A. & Slatopolsky, E. (1999) Vitamin D. American Journal of Physiology. Renal Physiology, 277, 46, F157–F175.
  • 8
    Hausler, M.R., Myrtle, J.F. & Norman, A.W. (1968) The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. Journal of Biological Chemistry, 243, 40554064.
  • 9
    Norman, A.W., Bishop, J.E., Bula, C.M., Olivera, C.J., Mizwicki, M.T., Zanello, L.P., Ishida, H. & Okamura, W.H. (2002) Molecular tools for study of genomic and rapid signal transduction responses initiated by 1α,25(OH)2-vitaminD3. Steroids, 67, 457466.
  • 10
    Huhtakangas, J.A., Olivera, C.J., Bishop, J.E., Zanello, L.P. & Norman, A.W. (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Molecular Endocrinology, 18, 26602671.
  • 11
    Veldman, C.M., Cantorna, M.T. & DeLuca, H.F. (2000) Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Archives of Biochemistry and Biophysics, 374, 334338.
  • 12
    Krall, E.A., Sahyoun, N., Tannenbaum, S., Dallal, G.E. & Dawson-Hughes, B. (1989) Effect of vitamin D intake on seasonal variations in parathyroid secretion in postmenopausal women. New England Journal of Medicine, 321, 17771783.
  • 13
    Brot, C., Vestergaard, P., Kolthoff, N., Gram, J., Herman, A.P. & Sørensen, O.H. (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. British Journal of Nutrition, 86, S97S103.
  • 14
    Parfitt, A. & , M. (1998) Osteomalacia and related disorders. In: L.V.Avioli, S.M.Krane eds. Metabolic Bone Diseases and Clinically Related Disorders. Academic Press, San Diego, 327386.
  • 15
    Lips, P. (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews, 22, 477501.
  • 16
    Zehnder, D., Bland, R., Williams, M.C., McNinch, R.W., Howie, A.J., Steward, P.M. & Hewison, M. (2001) Extrarenal expression of 25-hydroxyvitamin D3-1alphahydroxylase. Journal of Clinical Endocrinology and Metabolism, 86, 888894.
  • 17
    Tangpricha, V., Flanagan, J.N., Whitlatch, L.W., Tseng, C.C., Chen, T.C., Holt, P.R., Lipkin, M.S. & Holick, M.F. (2001) 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet, 357, 16731674.
  • 18
    Segersten, U., Correa, P., Hewison, Hellman, P., Dralle, H., Carling, T., Akerstrom, G. & Westin, G. (2002) 25-Hydroxyvitamin D3-1alpha-hydroxylase expression in normal and pathological parathyroid glands. Journal of Clinical Endocrinology and Metabolism, 87, 29672972.
  • 19
    Glerup, H., Mikkelsen, K., Poulsen, L., Hass, E., Overbeck, S., Thomsen, J., Charles, P. & Eriksen, E.F. (2000) Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. Journal of Internal Medicine, 247, 260268.
  • 20
    Iqbal, S.J., Kaddam, I., Wassif, W., Nichol, F. & Walls, J. (1994) Continuing clinically severe vitamin D deficiency in Asians in the UK (Leicester). Postgraduate Medical Journal, 70, 708714.
  • 21
    Iqbal, S.J., Featherstone, S., Kaddam, I.M.S., Mortimer, J. & Manning, D. (2001) Family screening is effective in picking up undiagnosed Asian vitamin D deficient subjects. Journal of Human Nutrition and Dietetics, 14, 371376.
  • 22
    Shaw, N.J. & Pal, B.R. (2002) Vitamin D deficiency in UK Asian families: activation of new concern. Archives of Disease in Childhood, 86, 147149.
  • 23
    Rejnmark, L., Jorgensen, M.E., Pedersen, M.B., Hansen, J.C., Heickendorff, L., Lauridsen, A.L., Mulvad, G., Siggaard, C., Skjoldborg, H., Sørensen, T.B., Pedersen, E.B. & Mosekilde, L. (2004) Vitamin D insufficiency in Greenlanders on a westernized fare. Ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcified Tissue International, 74, 255263.
  • 24
    Awumey, E.M., Mitra, D.A. & Hollis, B.W. (1998) Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research study. Journal of Clinical Endocrinology and Metabolism, 83, 169173.
  • 25
    Toss, G., Almqvist, S., Larsson, L. & Zetterqvist, H. (1980) Vitamin D deficiency in welfare institutions for the aged. Acta Medica Scandinavica, 208, 8789.
  • 26
    Dawson-Hughes, B., Harris, S.S., Krall, E.A. & Dallal, G.E. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New England Journal of Medicine, 337, 670676.
  • 27
    Flicker, L., Mead, K., McInnis, R., Nowson, C., Scherer, S., Stein, M., Thomas, J., Hopper, J. & Wark, J. (1999) Association between vitamin D, falls and fractures in older women in residential care in Australia. Journal of the American Geriatrics Society, 47, 11951201.
  • 28
    Holick, M.F., Matsuoka, L.Y. & Wortsman, J. (1989) Age, vitamin D, and solar ultraviolet radiation. Lancet, 4, 11041105.
  • 29
    Lau, K.-H.W. & Baylink, D.J. (1999) Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcified Tissue International, 65, 295306.
  • 30
    Muhe, L., Lulseged, S., Mason, K.E. & Simoes, E.A.F. (1997) Case–control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet, 349, 18011804.
  • 31
    Chan, T.Y.K. (2000) Vitamin D deficiency and susceptibility to tuberculosis. Calcified Tissue International, 66, 476478.
  • 32
    Dietrich, T., Joshipura, K.J., Dawson-Hughes, B. & Bischoff-Ferrari, H.A. (2004) Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. American Journal of Clinical Nutrition, 80, 108113.
  • 33
    The EURODIAB Substudy 2 Study Group (1999) Vitamin D supplementation in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 42, 5154.
  • 34
    Stene, L.C., Ulriksen, J., Magnus, P. & Joner, G. (2000) Use of cod liver oil during pregnancy is associated with lower risk of type 1 diabetes in the offspring. Diabetologia, 43, 10931098.
  • 35
    Hyppönen, E., Laara, E., Reunanen, A., Jarvelin, M.R. & Virtanen, S.M. (2001) Intake of vitamin D and intake of type 1 diabetes: a birth cohort study. Lancet, 358, 15001503.
  • 36
    Stene, L.C. & Joner, G. (2003) Use of cod liver oil during the first year of life is associated with a lower risk of childhood-onset type 1 diabetes: a large population based case control study. American Journal of Clinical Nutrition, 78, 11281134.
  • 37
    Merlino, L.A., Curtis, J., Mikuls, T.R., Cerhan, J.R., Criswell, L.A. & Saag, K.G. (2004) Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis and Rheumatism, 50, 7277.
  • 38
    Podolsky, D.K. (1991) Inflammatory bowel disease. New England Journal of Medicine, 324, 9281016.
  • 39
    Jahnsen, J., Falch, J.A., Mowinckel, Z.P. & Aadland, E. (2002) Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 37, 192197.
  • 40
    Lamb, E.J., Wong, T., Smith, D.J., Simpson, D.E., Coakley, A.J., Moniz, C. & Muller, A.F. (2002) Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 16, 18951902.
  • 41
    Hayes, C.E. (2000) Vitamin D: a natural inhibitor of multiple sclerosis. Proceedings of the Nutrition Society, 59, 531535.
  • 42
    Van der Mei, I.A., Ponsonby, A.L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B.V., Butzkueven, H. & Kilpatrick, T. (2003) Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case control study. British Medical Journal, 327, 216.
  • 43
    Mosekilde, L., Hermann, A.P., Beck-Nielsen, H., Charles, P., Nielsen, S.P. & Sorensen, O.H. (1999) The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2016 normal perimenopausal women. Maturitas, 31, 207209.
  • 44
    Dawson-Hughes, B., Dallal, G.E., Krall, E.A., Harris, S., Sokol, L.J. & Falconer, G. (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Annals of Internal Medicine, 115, 505512.
  • 45
    Ooms, M.E. (1994) Osteoporosis in elderly women: vitamin D deficiency and other risk factors. PhD Thesis, Vrije University, Amsterdam.
  • 46
    Ooms, M.E., Lips, P., Roos, J.C., Van Der Vijgh, W.J.F., Poop-Snijders, C., Bezemer, P.D. & Bouter, L.M. (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. Journal of Bone and Mineral Research, 10, 11771184.
  • 47
    Chapuy, M.C., Preziosi, P., Maamer, M., Arnaud, S., Galan, P., Hercberg, S. & Meunier, P.J. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International, 7, 439443.
  • 48
    Guillemant, J., Taupin, P., Le, H.T., Taright, N., Allemandou, A., Peres, G. & Guillemant, S. (1999) Vitamin D status during puberty in French healthy male adolescents. Osteoporosis International, 10, 222225.
  • 49
    Jesudason, D., Need, A.G., Horowitz, M., O'Loughlin, P.D., Morris, H.A. & Nordin, B.E. (2002) Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone, 31, 626630.
  • 50
    Vieth, R., Ladak, Y. & Walfish, P.G. (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism, 88, 185191.
  • 51
    Malabanan, A., Veronikis, I.E. & Holick, M.F. (1998) Redefining vitamin insufficiency. Lancet, 351, 805806.
  • 52
    Glerup, H. (1999) Investigations on the role of vitamin D in muscle function – A study of muscle function in vitamin D deficient humans and the effect of treatment with vitamin D. PhD Thesis, Aarhus University, Denmark.
  • 53
    Jongen, M.J.M., Van Der Vijgh, W.J.F., Berensteyn, E.C.H., Van Der Berg, H., Bosch, R., Hoogenboezem, T., Visser, T.J. & Netelenbos, J.C. (1982) Interlaboratory variation of vitamin D metabolite measurements. Journal of Clinical Chemistry and Clinical Biochemistry, 20, 753756.
  • 54
    Lips, P., Chapuy, M.C., Dawson-Hudges, B., Pols, H.A.P. & Holick, M.F. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporosis International, 9, 394397.
  • 55
    Baker, M.R., McDonnall, H., Peackok, M. & Nordin, B.E. (1997) Plasma 25-hydroxyvitamin D concentrations in patients with fractures of the femoral neck. British Medical Journal, 1, 589.
  • 56
    Lips, P., Van Ginkel, F.C., Jongen, M.J.M., Rubertus, A., Van Der Vijgh, W.J.F. & Netelenbos, J.C. (1987) Determinants of vitamin D status in patients with hip fracture and elderly control subjects. American Journal of Clinical Nutrition, 46, 10051010.
  • 57
    Center, J.R., Nguyen, T.V., Sambrook, P.N. & Eisman, J.A. (2000) Hormonal and biochemical parameters and osteoporotic fractures in elderly men. Journal of Bone and Mineral Research, 15, 14051411.
  • 58
    Larsen, E.R. (2002) Fall and fractures among elderly community residents: risk factors and prevention. PhD Thesis, Faculty of Health Sciences, University of Aarhus, Denmark.
  • 59
    Egsmose, C., Lund, B., McNair, P., Lund, B., Storm, T. & Sorensen, O.H. (1987) Low serum levels of 25-dihydroxyvitamin D in institutionalized old people: influence of solar exposure and vitamin D supplementation. Age and Ageing, 16, 3540.
  • 60
    Lund, B., Sørensen, O.H., Lund, B., Melsen, F. & Mosekilde, L. (1982) Vitamin D metabolism and osteomalacia in patients with fractures of the proximal femur. Acta Orthopedica Scandinavica, 53, 251254.
  • 61
    Aaron, J.E., Gallagher, J.C., Anderson, J., Stasiak, L., Longton, E.B., Nordin, B.E.C. & Nicholson, M. (1974) Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet, 1, 229233.
  • 62
    Hoikka, V., Alhava, E.M., Savolainen, K. & Parvianinen, M. (1982) Osteomalacia in fractures of the proximal femur. Acta Orthopedica Scandinavica, 53, 255260.
  • 63
    Hordon, L.D. & Peacock, M. (1990) Osteomalacia and osteoporosis in femoral neck fracture. Journal of Bone and Mineral Research, 11, 247259.
  • 64
    Lips, P., Netelenbos, J.C., Jongen, M.J., Van Ginkel, F.C., Althuis, A.L., Van Schaik, C.L., Van Der Vijgh, W.J., Vermeiden, J.P. & Van Der Meer, C. (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metabolic Bone Disease and Related Research, 4, 8593.
  • 65
    Von Knorring, J., Slätis, P., Weber, Th. & Helenius, T. (1982) Plasma levels of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in Southern Finland. Clinical Endocrinology, 17, 189194.
  • 66
    Bischoff, H.A., Stahelin, H.B., Tyndall, A. & Theiler, R. (2000) Relationship between muscle strength and vitamin D metabolites: are there therapeutic possibilities in the elderly? Zeitschrift für Rheumatologie, 29 (Suppl 1), 3941.
  • 67
    Chapuy, M.C., Durr, F. & Chapuy, P. (1983) Age-related changes in parathyroid hormone and 25 hydroxy-cholecalciferol levels. Journal of Gerontology, 38, 1922.
  • 68
    Stein, M.S., Wark, J.D., Scherer, S.C., Walton, S.L., Chick, P., Di Carlantonio, M., Zajac, J.D. & Flicker, L. (1999) Falls related to vitamin D and parathyroid hormone in an Australian nursing home and hostel. Journal of the American Geriatrics Society, 47, 195201.
  • 69
    Pfeifer, M., Begerow, B., Minne, H.W., Schlotthauer, T., Pospeschill, M. & Scholz, M. (2001) Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Experimental and Clinical Endocrinology and Diabetes, 109, 8792.
  • 70
    Pfeifer, M., Begerow, B., Minne, H.W., Nachtigall, D. & Hansen, C. (2001) Effect of short-term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. Journal of Clinical Endocrinology and Metabolism, 86, 16331637.
  • 71
    Dhesi, J.K., Bearne, L.M., Moniz, C., Hurley, M.V., Jackson, S.H., Swift, C.G. & Allain, T.J. (2002) Neuromuscular and psychomotor function in elderly people who fall and the relationship with vitamin D status. Journal of Bone and Mineral Research, 17, 891897.
  • 72
    Sørensen, O.H., Lund, B., Saltin, B.J., Lund, R.B., Andersen, L., Hjorth, F., Melsen, F. & Mosekilde, L. (1979) Myopathy in bone loss of ageing: improvement by treatment with 1-α-hydroxycholecalciferol and calcium. Clinical Science, 56, 157161.
  • 73
    Grady, D., Halloran, B., Cummings, S., Leveille, S., Wells, L., Black, D. & Byl, N. (1991) 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly in a randomised controlled trial. Journal of Clinical Endocrinology and Metabolism, 73, 11111117.
  • 74
    Boland, R. (1986) Role of vitamin D in skeletal muscle function. Endocrine Reviews, 7, 433438.
  • 75
    Pfeifer, M., Begerow, B. & Minne, H.W. (2002) Vitamin D and muscle function. Osteoporosis International, 13, 187194.
  • 76
    Simpson, R.U., Thomas, G.A. & Arnold, A.J. (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and action in muscle. Journal of Biological Chemistry, 260, 88828891.
  • 77
    Costa, E.M., Blau, H.M. & Feldman, D. (1986) 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology, 119, 22142220.
  • 78
    Rodman, J.S. & Baker, T. (1978) Changes in the kinetics of muscle contraction in vitamin D depleted rats. Kidney International, 13, 189.
  • 79
    Pointon, J.J., Francis, M.J. & Smith, R. (1979) Effect of vitamin D deficiency on sarcoplasmatic reticulum function and troponin C concentrations of rabbit skeletal muscle. Clinical Science, 57, 257263.
  • 80
    Bellido, T., Boland, R., Teresita, B.B. & Ricardo, B.B. (1991) Effects of 1,25-dihydroxyvitamin D3 on phosphate accumulation by myoblasts. Hormone and Metabolic Research, 23, 113116.
  • 81
    Boland, R., De Boland, A.R., Ritz, E. & Hasselbach, W. (1983) Effect of 1,25-dihydroxycholecalciferol on sarcoplasmic reticulum calcium transport in strontium fed chicken. Calcified Tissue International, 35, 190194.
  • 82
    Joborn, C., Rastad, J., Stalberg, E., Akerstrom, G. & Ljunghall, S. (1989) Muscle function in patients with primary hyperparathyroidism. Muscle and Nerve, 12, 8794.
  • 83
    Garber, A.J. (1983) Effect of parathyroid function on skeletal muscle protein and amino acid metabolism in the rat. Journal of Clinical Investigation, 71, 18061821.
  • 84
    Graafmans, W.C., Ooms, M.E., Hofstee, H.M., Bezemer, P.D., Bouter, L.M. & Lips, P. (1996) Falls in the elderly: a prospective study of risk factors and risk profiles. American Journal of Epidemiology, 143, 11291136.
  • 85
    Trivedi, D.P., Doll, R. & Khaw, K.T. (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal, 326, 469475.
  • 86
    Latham, N.K., Anderson, C.S., Lee, A., Bennet, D.A., Moseley, A. & Cameron, I.D. for the Fitness Collaborative Group (2003) A randomised, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: The frailty intervention trial in elderly subjects (FITNESS). Journal of the American Geriatric Society, 51, 291299.
  • 87
    Pfeifer, M., Begerow, B., Minne, H.W., Abrams, C., Nachtigall, D. & Hansen, C. (2000) Effects of a short term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. Journal of Bone and Mineral Research, 15, 11131118.
  • 88
    Bischoff, H.A., Stähelin, H.B., Dick, W., Akos, R., Knecht, M., Salis, C., Nebiker, M., Theiler, R., Pfeifer, M., Begerow, B., Lew, R.A. & Conzelmann, M. (2003) Effect of vitamin D and calcium supplementation on falls: a randomized controlled study. Journal of Bone and Mineral Research, 18, 343351.
  • 89
    Harwood, R.H., Sahota, O., Gaynor, K., Masud, T. & Hosking, D.J. (2004) The Nottingham Neck of Femur (NONOF) study. Age and Ageing, 33, 4551.
  • 90
    Bischoff-Ferrari, H.A., Dawson-Hughes, B., Willett, W.C., Staehelin, H.B., Bazemore, M.G., Zee, R.Y. & Wong, J.B. (2004) Effect of vitamin D on falls: a meta-analysis. The Journal of the American Medical Association, 291, 19992006.
  • 91
    Sahota, O., Masud, T., San, P. & Hoskin, D.J. (1999) Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clinical Endocrinology, 51, 217221.
  • 92
    Dawson-Hughes, B., Harris, S.S., Krall, E.A. & Dallal, G.E. (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. American Journal of Nutrition, 72, 745750.
  • 93
    Johnell, O., Gullberg, B., Kanis, J.A., Allander, E., Elffors, L., Dequecker, J., Dilsen, G., Gennari, C., Vas Lopez, A. & Lyritis, G. (1995) Risk factors for hip fracture in European women: the MEDOS study, Mediterranean Osteoporosis Study. Journal of Bone and Mineral Research, 10, 18021815.
  • 94
    Cooper, C., McLaren, M., Wood, P.J., Coulton, L. & Kanis, J.A. (1989) Indices of calcium metabolism in women with hip fractures. Bone and Mineral, 5, 193200.
  • 95
    Boonen, S., Vanderschueren, D., Cheng, X.G., Verbeke, G., Dequecker, J., Geusens, P., Broos, P. & Bouillon, R. (1997) Age related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D and androgen deficiency induced bone resorption. Journal of Bone and Mineral Research, 12, 21192126.
  • 96
    Chapuy, M.C., Arlot, M.E., Duboeuf, F., Brun, J., Crouzet, B., Arnoud, S., Delmas, P.D. & Meunier, P.J. (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. New England Journal of Medicine, 372, 16371642.
  • 97
    Chapuy, M.C., Arlot, M.E., Delmas, P.D. & Meunier, P.J. (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. British Medical Journal, 308, 10811082.
  • 98
    Chapuy, M.C., Pamphile, R., Paris, E., Kempf, C., Schlicting, M., Arnaud, S., Garnero, P. & Meunier, P.J. (2002) Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis International, 13, 257264.
  • 99
    Gillespie, W.J., Avenell, A., Henry, D.A., O'Connell, D.L. & Robertson, J. (2003) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review) I. The Cochrane Library, issue 1. Update Software, Oxford.
  • 100
    Meyer, H.E., Smedshaug, G.B., Kvaavik, E., Falch, J.A., Tverdal, A. & Pedersen, J.I. (2002) Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomised controlled trial. Journal of Bone and Mineral Research, 17, 709715.
  • 101
    Heikinheimo, R.J., Inkovaara, J.A., Harju, E.J., Haavisto, M.V., Kaarela, R.H., Kataja, J.M., Kokko, A.M., Kolho, L.A. & Rajala, S.A. (1992) Annual injection of vitamin D and fractures of aged bones. Calcified Tissue International, 51, 105110.
  • 102
    Lips, P., Graafmans, W.C., Ooms, M.E., Bezemer, P.D. & Bouter, L.M. (1996) Vitamin D supplementation and fracture incidence in elderly persons. Annals of Internal Medicine, 124, 400406.
  • 103
    Larsen, E.R., Mosekilde, L. & Foldspang, A. (2004) Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. Journal of Bone and Mineral Research, 19, 370378.
  • 104
    Smith, H., Anderson, F., Raphael, H., Crozier, S. & Cooper, C. (2004) Effect of annual intramuscular vitamin D supplementation on fracture risk: population-based, randomised, double-blind, placebo-controlled trial. Osteoporosis International, 15, S8 (Abstract).
  • 105
    Van den Bemd, G.J. & Chang, G.T. (2002) Vitamin D and vitamin D analogues in cancer treatment. Current Drug Targets, 3, 8594.
  • 106
    Krishnan, A.V., Peehl, D.M. & Feldman, D. (2003) Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression. Journal of Cellular Biochemistry, 88, 363371.
  • 107
    Zittermann, A. (2003) Vitamin D in preventive medicine: are we ignoring the evidence? British Journal of Nutrition, 89, 552572.
  • 108
    Pinette, K.V., Yee, Y.K., Amegadzie, B.Y. & Nagpal, S. (2003) Vitamin D receptor as a drug discovery target. Mini Reviews in Medicinal Chemistry, 3, 193204.
  • 109
    Guyton, K.Z., Kensler, T.W. & Posner, G.H. (2003) Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutrition Reviews, 61, 227238.
  • 110
    Garland, C.F. & Garland, F.C. (1980) Do sunlight and vitamin D reduce the likelihood of colon cancer? International Journal of Epidemiology, 9, 227231.
  • 111
    Garland, F.C., Garland, C.F., Gorham, E.D. & Young, J.F. (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Preventive Medicine, 19, 614622.
  • 112
    Lipkin, M., Newmark, H., Boone, C.W. & Kelloff, G.J. (1991) Calcium, vitamin D and colon cancer. Cancer Research, 51, 30693070.
  • 113
    Garland, C.F., Garland, F.C. & Gorham, E.D. (1999) Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Annals of the New York Academy of Sciences, 889, 107119.
  • 114
    Hanchette, C.L. & Schwartz, G.G. (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer, 70, 28612869.
  • 115
    Freedman, D.M., Dosemeci, M. & McGlynn, K. (2001) Sunlight and mortality from breast, ovarian, colon, prostate and non-melanoma skin cancer: a composite death certificate based case control study. Journal of Occupational and Environmental Medicine, 59, 257262.
  • 116
    Grant, W.B. (2002) An estimate of premature cancer mortality in the US due to inadequate doses of ultraviolet solar radiation. Cancer, 94, 18671875.
  • 117
    Grant, W.B. (2002) An ecologic study on dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer, 94, 272281.
  • 118
    Grant, W.B. (2003) Ecologic studies of solar UV-B radiation and cancer mortality. Recent Results in Cancer Research, 164, 371377.
  • 119
    Grant, W.B. (2004) A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. European Urology, 45, 271279.
  • 120
    Gorham, E.D., Garland, F. & Garland, C. (1990) Sunlight and breast cancer incidence in USSR. International Journal of Epidemiology, 19, 820824.
  • 121
    Cross, H.S., Peterlik, M., Reddy, G.S. & Schuster, I. (1997) Vitamin D metabolism in human colonadenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alfa-hydroxylase activity and regulation of side chain metabolism. Journal of Steroid Biochemistry and Molecular Biology, 62, 2128.
  • 122
    Holt, P.R., Arber, N. & O'Connor, J. (2000) Serum 25 hydroxyvitamin D3 inhibits proliferation of colonic epithelial cells in subjects at high risk for colon neoplasia. Gastroenterology, 118, A276.
  • 123
    Garland, C., Shekelle, R.B., Barrett-Connor, E., Criqui, M.H., Rossof, A.H. & Oglesby, P. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in man. Lancet, 1, 307309.
  • 124
    Garland, C.F., Garland, F.C. & Gorham, E.D. (1991) Can colon cancer incidence and death rates be reduced with calcium and vitamin D? American Journal of Clinical Nutrition, 54, 193S210S.
  • 125
    Garland, C.F., Comstock, G.W., Garland, F.C., Helsing, K.J., Shaw, E.K. & Gorham, E.D. (1989) Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2, 11761178.
  • 126
    McCulough, M.L., Robertson, A.S., Rodriguez, C., Jacobs, A.J., Chao, A., Jonas, C., Calle, E.E., Willett, W.C. & Thun, M.J. (2003) Calcium, vitamin D, dietary products, and risk of colorectal cancer in the cancer prevention study II nutrition cohort (United States). Cancer Causes and Control, 14, 112.
  • 127
    Schwartz, G.G., Whitlatch, L.W., Chen, T.C., Lokeswar, B.L. & Holick, M.F. (1998) Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiology, Biomarkers and Prevention, 7, 391395.
  • 128
    Whitlatch, L.W., Young, M.V., Schwartz, G.G., Flanagan, J.N., Burnstein, K.L., Lokeshwar, B.L., Rich, E.S., Holick, M.F. & Chen, T.C. (2002) 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. Journal of Steroid Biochemistry and Molecular Biology, 81, 135140.
  • 129
    Chen, T.C., Wang, L., Whitlatch, L.W., Flanagan, J.N. & Holick, M.F. (2003) Prostatic 25-hydroxyvitamin D-1alfa-hydroxylase and its implication in prostate cancer. Journal of Cellular Biochemistry, 88, 315322.
  • 130
    Baretto, A.M., Schwartz, G.G., Woodruff, R. & Cramer, S.D. (2000) 25-Hydroxyvitamin D3 the prohormone of 1,25-dihydroxyvitamin D3 inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology, Biomarkers and Prevention, 9 , 265270.
  • 131
    Peehl, D.M., Krishnan, A.V. & Feldman, D. (2003) Pathways mediating the growth-inhibitory actions of vitamin D in prostatic cancer. Journal of Nutrition, 133, 2461S2469S.
  • 132
    Taylor, J.A., Hirvonen, A., Watson, M., Pittman, G., Mohler, J.L. & Bell, D.A. (1996) Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Research, 56, 41084110.
  • 133
    Ahonen, M.H., Tenkanen, L., Teppo, L., Hakama, M. & Tuoimaa, P. (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes and Control, 11, 847852.
  • 134
    Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Statin, P., Harvei, S., Hakulinen, T., Luostarinen, T., Dillner, J., Lehtinen, M. & Hakama, M. (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal nested case–control study in the Nordic countries. International Journal of Cancer, 108, 104108.
  • 135
    Welsh, J., Wietzke, J.A., Zinser, G.M., Byrne, B., Smith, K. & Narvaez, C.J. (2003) Vitamin D-3 receptor as a target for breast cancer prevention. Journal of Nutrition, 133, 2425S2433S.
  • 136
    Koga, M., Eisman, J.A. & Sutherland, R.L. (1988) Regulation of epidermal growth factor receptor level by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Research, 48, 27342739.
  • 137
    Frappart, L., Falette, N., Lefebre, M.F., Bremond, A., Vauzelle, J.L. & Saez, S. (1989) In vitro study of effects of 1,25 dihydroxy vitamin D3 on the morphology of human breast cancer cell line B.T.20. Differentiation, 40, 6369.
  • 138
    John, E.M., Schwartz, G.G., Dreon, D.M. & Koo, J. (1999) Vitamin D and breast cancer risk: the NHANES I epidemiological follow-up study, 1971–1975 to 1992. National health and nutrition examination study. Cancer Epidemiology, Biomarkers and Prevention, 8, 399406.
  • 139
    Shin, M.H., Holmes, M.D., Hankinson, S.E., Wu, K., Colditz, G.A. & Willet, W.C. (2002) Intake of dietary products, calcium, and vitamin D and risk of breast cancer. Journal of the National Cancer Institute, 94, 13011311.
  • 140
    Ortlepp, J.R., Lauscher, J., Hoffmann, R., Hanrath, P. & Joost, H.G. (2001) The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabetic Medicine, 18, 842845.
  • 141
    Norman, A.W., Frankel, B.J., Heldt, A.M. & Grodsky, G.M. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 209, 823825.
  • 142
    Boucher, B.J. (1998) Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’? British Journal of Nutrition, 79, 315327.
  • 143
    Zemmel, M.B., Hang, S., Greer, B., Dirienzo, D. & Zemel, P.C. (2000) Regulation of adiposity by dietary calcium. The FASEB Journal, 14, 11321138.
  • 144
    Nyomba, B.L., Bouillon, R. & DeMoor, P. (1984) Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology, 115, 191197.
  • 145
    Cade, C. & Norman, A.W. (1986) Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology, 119, 8490.
  • 146
    Gedik, O. & Akalin, S. (1986) Effects of vitamin D deficiency and repletion on insulin and glucagons secretion in man. Diabetologia, 29, 142145.
  • 147
    Pietschmann, P., Schernthaner, G. & Woloszczuk, W. (1988) Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia, 31, 892895.
  • 148
    Isaia, G., Giorgino, R. & Adami, S. (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care, 24, 1496.
  • 149
    Scragg, R., Khaw, K.T. & Murphy, S. (1995) Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. European Journal of Clinical Nutrition, 49, 640646.
  • 150
    Ishii, H., Suzuli, H., Baba, T., Nakamura, K. & Watanabe, T. (2001) Seasonal variation of glycemic control in type 2 diabetic patients. Diabetes Care, 24, 1503.
  • 151
    Colas, C., Garabedian, M., Fontbonne, A., Guillozo, H., Slama, G., Desplanque, N., Dauchy, F. & Tchobroutsky, G. (1988) Insulin secretion and plasma 1,25(OH)2D after UV-B irradiation in healthy adults. Hormone and Metabolic Research, 21, 154155.
  • 152
    Borissova, A.M., Tankova, T., Kirilov, G., Dakovska, L. & Kovacheva, R. (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. International Journal of Clinical Practice, 57, 258261.
  • 153
    Chiu, K.C., Chu, A., Go, V.L.W. & Saad, M.F. (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. American Journal of Clinical Nutrition, 79, 820825.
  • 154
    Carnevale, V., Romagnoli, E. & D’Erasmo, E. (2004) Skeletal involvement in patients with diabetes mellitus. Diabetes/Metabolism Research and Reviews, 20, 196204.
  • 155
    Simpson, R.U. & Weishaar, R.E. (1988) Involvement of 1,25-dihydroxyvitamin D3 in regulating myocardial metabolism: physiological and pathological actions. Cell Calcium, 9, 285292.
  • 156
    Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R. & Stehle, P. (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology, 41, 105112.
  • 157
    Scragg, R., Jackson, R., Holdaway, I.M., Lim, T. & Beaglehole, R. (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. International Journal of Epidemiology, 19, 559563.
  • 158
    Douglas, A.S., Rawles, J.M., Alexander, E. & Allan, T.M. (1991) Winter pressure in hospital medical beds. British Medical Journal, 303, 508509.
  • 159
    Hegarty, V., Woodhause, P. & Khaw, K.T. (1994) Seasonal variation in 25-hydroxyvitamin D and parathyroid hormone concentrations in elderly people. Age and Ageing, 23, 478482.
  • 160
    Rostand, S.G. (1997) Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension, 30, 150156.
  • 161
    Resnick, L.M., Muller, F.B. & Laragh, J.H. (1986) Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Annals of Internal Medicine, 105, 649654.
  • 162
    McCarron, D.A., Morris, C.D. & Bukoski, R. (1987) The calcium paradox of essential hypertension. American Journal of Medicine, 82, 2733.
  • 163
    Strazzullo, P. (1991) The renal leak in primary hypertension: pathophysiological aspects and clinical implications. Nutrition, Metabolism, and Cardiovascular Diseases, 1, 98103.
  • 164
    MacGregor, G.A. & Cappucio, F.P. (1993) The kidney and essential hypertension: a link to osteoporosis? Journal of Hypertension, 11, 781785.
  • 165
    Nemere, I., Zhou, L.X. & Norman, A.W. (1993) Nontranscriptional effects of steroid hormones. Receptor, 3, 277291.
  • 166
    Scragg, R., Holdaway, I., Jackson, R. & Lim, T. (1992) Plasma 25-hydroxyvitamin D3 and its relation to physical activity and other heart disease risk factors in the general population. Annals of Epidemiology, 2, 697703.
  • 167
    Pan, W.H., Wang, C.Y. & Li, L.A. (1993) No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese. Chinese Journal of Physiology, 36, 8594.
  • 168
    Scragg, R., Holdaway, I., Singh, V., Metcalf, P., Baker, J. & Dryson, E. (1995) Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Research and Clinical Practice, 27, 181188.
  • 169
    Lind, L., Wengle, B. & Ljunghall, S. (1987) Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double blind placebo controlled study. Acta Medica Scandinavica, 222, 423427.
  • 170
    Lind, L., Lithell, H., Skarfors, E., Wide, L. & Ljunghall, S. (1988) Reduction of blood pressure by treatment with alfacalcidiol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Medica Scandinavica, 223, 211427.
  • 171
    Krause, R., Buhring, M., Hopfenmühller, W., Holick, M.F. & Sharma, A.M. (1998) Ultraviolet B and blood pressure. Lancet, 352, 709710.
  • 172
    Danish Institute for Food and Veterinary Research (2004) Vitamin D status in the Danish population should be improved. (In Danish with English summary.) Available online at: http://www.netboghandel.dk or http://www.dfvf.dk.
  • 173
    Blank, S., Scanlon, K.S., Sinks, T.H., Lett, S. & Falk, H. (1995) An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. American Journal of Public Health, 85, 656659.
  • 174
    Scanlon, K.S., Blank, S., Sinks, T., Lett, S., Mueller, P., Freedman, D.S., Serdula, M. & Falk, H. (1995) Subclinical health effects in a population exposed to excess vitamin D in milk. American Journal of Public Health, 85, 14181422.
  • 175
    Holick, M.F., Shao, Q., Liu, W.W. & Chen, T.C. (1992) The vitamin D content of fortified milk and infant formula. New England Journal of Medicine, 326, 11781181.
  • 176
    Scientific Committee on Food (2002) Opinion of the Scientific Committee on Food on the tolerable upper intake level of vitamin D. Scientific Committee on Food, The European Commission, Brussels.
  • 177
    Vieth, R.W. (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. American Journal of Clinical Nutrition, 69, 842856.
  • 178
    Stephens, W.P., Klimiuk, P.S., Berry, J.L. & Mawer, E.B. (1981) Annual high-dose vitamin D prophylaxis in Asian immigrants. Lancet, 28, 11991202.